S. Atalay, “Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice”, Acta Derm Venereol, vol. 101, no. 5, p. adv00463, May 2021.